OncoSec Medical (ONCSQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock ONCSQ vs. CLVR, EFTR, PXMD, ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, AMPE, and ACABWShould you be buying OncoSec Medical stock or one of its competitors? The main competitors of OncoSec Medical include Clever Leaves (CLVR), eFFECTOR Therapeutics (EFTR), PaxMedica (PXMD), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Ampio Pharmaceuticals (AMPE), and Atlantic Coastal Acquisition Corp. II (ACABW). These companies are all part of the "pharmaceutical products" industry. OncoSec Medical vs. Its Competitors Clever Leaves eFFECTOR Therapeutics PaxMedica 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Ampio Pharmaceuticals Atlantic Coastal Acquisition Corp. II OncoSec Medical (NASDAQ:ONCSQ) and Clever Leaves (NASDAQ:CLVR) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation. Which has more risk and volatility, ONCSQ or CLVR? OncoSec Medical has a beta of -19.7, indicating that its share price is 2,070% less volatile than the S&P 500. Comparatively, Clever Leaves has a beta of 3440.04, indicating that its share price is 343,904% more volatile than the S&P 500. Is ONCSQ or CLVR more profitable? Company Net Margins Return on Equity Return on Assets OncoSec MedicalN/A N/A N/A Clever Leaves N/A N/A N/A Does the media prefer ONCSQ or CLVR? In the previous week, OncoSec Medical's average media sentiment score of 0.00 equaled Clever Leaves'average media sentiment score. Company Overall Sentiment OncoSec Medical Neutral Clever Leaves Neutral Which has higher earnings and valuation, ONCSQ or CLVR? Clever Leaves has higher revenue and earnings than OncoSec Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOncoSec MedicalN/AN/A-$34.18MN/AN/AClever Leaves$17.42M0.00-$17.90M-$11.31N/A Do insiders & institutionals believe in ONCSQ or CLVR? 6.9% of Clever Leaves shares are owned by institutional investors. 1.3% of OncoSec Medical shares are owned by insiders. Comparatively, 8.2% of Clever Leaves shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryClever Leaves beats OncoSec Medical on 5 of the 5 factors compared between the two stocks. Get OncoSec Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCSQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONCSQ vs. The Competition Export to ExcelMetricOncoSec MedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$839.03M$5.60B$9.11BDividend YieldN/A4.84%5.24%4.02%P/E RatioN/A1.1727.9620.25Price / SalesN/A241.37430.5799.61Price / CashN/A17.6937.4658.16Price / BookN/A6.528.045.49Net Income-$34.18M-$23.68M$3.18B$250.27M OncoSec Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONCSQOncoSec MedicalN/AN/AN/AN/A$1KN/A0.0040CLVRClever LeavesN/A$0.00flatN/AN/A$1K$17.42M0.00560EFTReFFECTOR Therapeutics0.0787 of 5 stars$0.00flatN/A-99.4%$1K$3.55M0.0010Gap DownPXMDPaxMedicaN/A$0.00flatN/AN/A$1KN/A0.002News CoverageATNFW180 Life SciencesN/A$0.01+7.5%N/A-2.4%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01flatN/A-83.4%$0.00N/A0.002AIMDWAinosN/A$0.13-13.3%N/A+70.4%$0.00$106.21K0.0040Gap UpALVOWAlvotechN/A$1.73+1.8%N/A-42.1%$0.00$585.60M0.004Positive NewsGap UpAMPEAmpio PharmaceuticalsN/A$0.00-96.3%N/A-99.9%$0.00N/A0.0020Gap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.02-0.5%N/AN/A$0.00N/A0.0015 Related Companies and Tools Related Companies Clever Leaves Alternatives eFFECTOR Therapeutics Alternatives PaxMedica Alternatives 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Ampio Pharmaceuticals Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ONCSQ) was last updated on 7/12/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoSec Medical Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share OncoSec Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.